G Michael Felker
Duke University
H-index: 107
North America-United States
Top articles of G Michael Felker
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Managing Obesity in Heart Failure: A Chance to Tip the Scales? | Josephine Harrington G Michael Felker Ildiko Lingvay Neha J Pagidipati Ambarish Pandey | 2024/1/1 | |
Prognostic impact of repeated NT-proBNP measurements in patients with heart failure with reduced ejection fraction | Heart Failure | Michael A Fuery Eric S Leifer Marc D Samsky Sounok Sen Christopher M O’Connor | 2024/3/1 |
Putting More Weight on Obesity Trials in Heart Failure | Josephine Harrington Naveed Sattar G Michael Felker James L Januzzi Carolyn SP Lam | 2024/4/15 | |
The effect of omecamtiv mecarbil in hospitalized patients as compared with outpatients with HFrEF: an analysis of GALACTIC-HF | Journal of Cardiac Failure | Kieran F Docherty John JV McMurray Rafael Diaz G Michael Felker Marco Metra | 2024/1/1 |
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping | Matthew G Dimond Nasrien E Ibrahim Mona Fiuzat John JV McMurray JoAnn Lindenfeld | 2024/3/1 | |
Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF | Journal of Cardiac Failure | Satoshi Shoji Lisa A Kaltenbach Bradi B Granger Gregg C Fonarow Hussein Al-Khalidi | 2024/4/8 |
Natriuresis-Guided Titration of Loop Diuretics in Heart Failure: Another Brick in the Wall | G Michael Felker | 2024/1 | |
Reply to'Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?' | European Journal of Heart Failure | Pierpaolo Pellicori G Michael Felker John GF Cleland | 2024/2/20 |
Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials | Circulation: Cardiovascular Quality and Outcomes | Pishoy Gouda Sarah Rathwell Eloisa Colin-Ramirez G Michael Felker Heather Ross | 2024/4/3 |
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper | Anuradha Lala Carine E Hamo Biykem Bozkurt Mona Fiuzat Vanessa Blumer | 2024/1/1 | |
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study | Journal of Cardiac Failure | G Michael Felker Scott D Solomon Marco Metra John JV Mcmurray Rafael Diaz | 2024/1/11 |
Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions | Josephine Harrington G Michael Felker James L Januzzi Carolyn SP Lam Ildiko Lingvay | 2024/3/29 | |
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231) | European Journal of Heart Failure | Pierpaolo Pellicori John GF Cleland Maria Borentain Jorg Taubel Fraser J Graham | 2024/1 |
Tricuspid regurgitation and clinical outcomes in heart failure with reduced ejection fraction | Heart Failure | Marianna Adamo Marco Metra Brian L Claggett Zi Michael Miao Rafael Diaz | 2024/3/1 |
Addition by Subtraction in Mechanical Cardiac Support | JAMA | G Michael Felker Joseph G Rogers | 2023/11/11 |
Electronic health record characterization and outcomes of heart failure with preserved ejection fraction | American Heart Journal | Vishal N Rao Derek D Cyr Lisa M Wruck Gretchen Sanders Paul Hofmann | 2023/9/1 |
Omecamtiv mecarbil in Black patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF | Heart Failure | David E Lanfear Joyce N Njoroge Kirkwood F Adams Inder Anand James C Fang | 2023/5/1 |
Circulating angiokines are associated with reverse remodeling and outcomes in chronic heart failure | Journal of Cardiac Failure | JOSEPHINE Harrington Andrew B Nixon Melissa A Daubert Eric Yow James Januzzi | 2023/6/1 |
Duration of Heart Failure, In-hospital Clinical Trajectory, and Postdischarge Outcomes in Patients Hospitalized for Heart Failure | Journal of Cardiac Failure | Jacob B Pierce Muhammad Haisum Maqsood Muhammad Shahzeb Khan Abdul Mannan Khan Minhas Javed Butler | 2023/2/1 |
CHARACTERISTICS AND OUTCOMES OF TRIAL-ELIGIBLE VS INELIGIBLE PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION | Journal of the American College of Cardiology | Anthony Peters Robert M Clare Karen E Chiswell Josephine Harrington Anita M Kelsey | 2023/3/7 |
Co-Authors
